Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430800 · ClinicalTrials.gov registry record · NA
Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
A NA study, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT07430800: Recruiting NA study, sponsored by University of Southern California.
NCT07430800 is a NA study that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07430800, a NA study, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
Untreated anxiety undermines long-term physical and emotional wellbeing, especially among college students, with rates worsening since the onset of the COVID-19 pandemic. Cognitive Behavioral Therapy (CBT) is the leading evidence-based intervention for anxiety, but many students fail to complete exercises between CBT sessions, reducing its effectiveness. Socially assistive robots (SARs) help promote adherence to home-based practice in the context of elder care, social skill learning, and physical therapy, but it is unknown how SARs can enhance CBT. The specific objective of this research is to develop personalized CBT SARs that can support CBT compliance for college students with anxiety. To meet the goals of the proposed work, these studies will determine how SAR personalization based on implicit and explicit feedback can help promote greater CBT compliance and anxiety reduction outcomes for students.
Primary Outcome
Using transcriptions of the interactions, the investigators will count the number of words uttered by the participant.
Interventions
- BEHAVIORAL Explicit CBT SAR Personalization for 6 weeks
- BEHAVIORAL Implicit CBT SAR Personalization for 6 weeks
- BEHAVIORAL Control CBT SAR for 6 weeks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2028-08-15 |
| Phase | NA |
What NCT07430800 shows while recruiting
NCT07430800 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Explicit CBT SAR Personalization for 6 weeks is the first listed.
NCT07430800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07430800 about?
NCT07430800 is a clinical study titled "Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety". Untreated anxiety undermines long-term physical and emotional wellbeing, especially among college students, with rates worsening since the onset of the COVID-19 pandemic. Cognitive Behavioral Therapy (CBT) is the leading evidence-based intervention for anxiety, but many students fail to complete exe...
What is the current status of trial NCT07430800?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2026-03-30. Estimated completion is 2028-08-15.
What interventions are being tested in trial NCT07430800?
The interventions under investigation include: Explicit CBT SAR Personalization for 6 weeks (BEHAVIORAL), Implicit CBT SAR Personalization for 6 weeks (BEHAVIORAL), Control CBT SAR for 6 weeks (BEHAVIORAL).
Who is sponsoring clinical trial NCT07430800?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07430800's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI